As the landscape of GIST treatment continues to evolve, the area of immunotherapy has grown interest. GIST contains tumor-infiltrating immune cells which opens the possibility to the rationale for immunotherapy treatments. This webinar provided an overview of immunotherapy with some examples of studies exploring single agent versus combination of therapy in GIST.
